Condition

Solid Tumor, Unspecified, Adult clinical trials and research

• 7Clinical trials
• 5Countries

Newest Solid Tumor, Unspecified, Adult clinical trials

All recruiting trials (7)

• Evaluating AD1208 for advanced solid tumors

  This study is testing a new drug called AD1208 to see if it is safe and tolerable for people with advanced solid tumors.

  Recruiting at 3 sites Phase 1/2 Avelos Therapeutics Inc. · Seongnam-si, Gyeonggi-do and 2 other locations · NCT06911333

• Testing LXP1788 Injection for Advanced Solid Tumors

  This study is testing a new injection called LXP1788 to see if it can safely help people with advanced solid tumors that haven't responded to other treatments.

  Recruiting at 2 sites Phase 1 LaunXP Biomedical Co., Ltd. · Taichung and 1 other locations · NCT06883539

• Genomic profiling for targeted treatment in patients with incurable cancer

  This study is testing if using genetic information from tumors can help find better treatment options for people with incurable cancer.

  Recruiting Aalborg University Hospital · Aalborg · NCT05695638

• Adapting a communication program for Latinx cancer patients

  This study is testing a new communication program to help Spanish-speaking cancer patients in the Bronx talk about their health values with their nurses.

  Recruiting at 5 sites Memorial Sloan Kettering Cancer Center · New York, New York and 4 other locations · NCT04942717

• Molecular analysis for cancer patients at Gustave Roussy

  This study is testing a way to find specific genetic changes in cancer patients to see if they can get targeted treatments that might work better for them.

  Recruiting at 2 sites Gustave Roussy, Cancer Campus, Grand Paris · Villejuif, Val de Marne and 3 other locations · NCT04932525

• Testing MPB-1734 in patients with advanced solid tumors

  This study is testing a new treatment called MPB-1734 to see if it's safe and effective for people with advanced solid tumors that can't be treated with standard therapies.

  Recruiting Phase 1/2 MegaPro Biomedical Co. Ltd. · Taipei · NCT04643418

• INV-1120 alone and with pembrolizumab for adults with advanced solid tumors

  This Phase 1 study will test whether the experimental drug INV-1120, given alone or with pembrolizumab, is safe and tolerable in adults with advanced solid tumors who have progressed after standard therapies.

  Recruiting Phase 1 Shenzhen Ionova Life Sciences Co., Ltd. · Lafayette, Indiana and 2 other locations · NCT04443088

Related topics

Quick answers

How many Solid Tumor, Unspecified, Adult clinical trials are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 5 countries. The most sites are in Taiwan (2 trials), United States (2 trials), France (1 trial), South Korea (1 trial), Denmark (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 2, Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →